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The objective of this study was to determine the prevalence of Potentially Inappropriate Medication (PIM) 
use and associated factors, as well as the prevalence of Prescribing Omissions (PO). A cross-sectional 
study was conducted in a philanthropic Brazilian nursing home involving 46 individuals aged 60 years 
or older. The following information was collected from medical records and drug prescriptions: gender, 
age, health conditions and drugs used in the past thirty days. PIM and PO were identified according to the 
Beers’ Criteria and the STOPP/START screening tools. Over one third (37%) of the population used at least 
one PIM according to the Beers’ Criteria (n=17) and 60.9% according to the STOPP tool. A significant 
association was found between polypharmacy (use of five or more drugs) and use of PIM according 
to the Beers’ Criteria, but not according to the STOPP. Eight residents (17.4%) were exposed to eight 
PO. This study allowed the diagnosis of a concerning drug utilization profile with use of a high number 
of PIMs. Thus, there is an evident need to implement strategies for improving geriatric prescription.
Uniterms: Pharmacoepidemiology. Pharmaceutical care. Elderly/inappropriate use of medicines. 
Medicines/inappropriate prescribing. Medicines/inappropriate use. Beers’ Criteria.
O objetivo deste estudo foi determinar a prevalência de uso de medicamentos potencialmente inadequados 
(MPI) e fatores associados, bem como a prevalência de omissões farmacoterapêuticas (OF). Trata-se de 
um estudo transversal realizado em uma instituição filantrópica brasileira de longa permanência com 
46 indivíduos com 60 anos ou mais. As seguintes informações foram coletadas a partir de prontuários e 
prescrições: sexo, idade, condições de saúde e medicamentos utilizados nos últimos trinta dias. MPI e 
OF foram identificados pelo Critério de Beers e as ferramentas de triagem STOPP/START. Mais de um 
terço (37%) da população utilizou pelo menos, um MPI de acordo com os critérios de Beers (n=17) e 
60.9% de acordo com a ferramenta STOPP. Associação estatisticamente significante foi detectada entre 
a polifarmácia (consumo de cinco ou mais medicamentos) e uso de MPI de acordo com os critérios de 
Beers, mas não de acordo com o STOPP. Oito residentes (17,4%) foram expostos a oito OF. Este estudo 
permitiu o diagnóstico de um perfil de utilização de medicamentos preocupante com número elevado 
de utilização de MPI. Isso indica a necessidade de implementar estratégias para melhorar a qualidade 
da prescrição geriátrica.
Unitermos: Farmacoepidemiologia. Atenção farmacêutica. Idoso/uso inapropriado de medicamentos. 
Medicamentos/prescrição inadequada. Medicamentos/uso inapropriado. Critério de Beers.
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INTRODUCTION
The aging process in developing countries has 
occurred at a fast pace, particularly in Brazil, where the 
number of elderly has increased from 3 to 20.5 million in 
the last 50 years (1960 to 2010) (IBGE, 2010).
Demographic changes in the Brazilian population 
have been accompanied by an epidemiological transition, 
which is characterized by a reduction in the incidence of 
infectious and parasitic diseases and a progressive increase 
in the occurrence of chronic diseases predominantly 
affecting the elderly population (Schramm et al., 2004). 
This health profile weakens and reduces the independence 
of the elderly population, generating a continuous 
and growing demand for multidisciplinary health care 
teams, hospitalizations, use of medications and even 
institutionalization (Berenstein, Wajnman, 2008).
In this scenario, the use of multiple medications 
encompasses risks and benefits. For this reason, the 
appropriateness of drugs prescription and use are important 
indicators for assessing the quality of health for the elderly.
The process of selecting drugs for the elderly 
should be made with caution, since the use of some 
active ingredients may present more risks than benefits in 
this age group (Hamilton, Gallagher, O’Mahony, 2009). 
Such medications are called Potentially Inappropriate 
Medications (PIM). The Beers’ Criteria and the STOPP 
(Screening Tool of Older Persons’ Potentially Inappropriate 
Prescriptions) are important references that list drug 
classes, specific medications and prescribing patterns 
that fit this category (Fick et al., 2003; O’Mahony et al., 
2010). Moreover, the nonprescription of needed drugs, or 
Prescribing Omissions (PO), also represents an important 
problem that can be detected by the START (Screening 
Tool to Alert to Right Treatment): a list of prescription 
patterns that should be implemented when a specific 
diagnosis is detected (O’Mahony et al., 2010).
International studies show that the use of PIM and 
the occurrence of PO are associated with an increased risk 
of falls, fractures, postoperative confusion, gastrointestinal 
bleeding, constipation, worsening of congestive heart 
failure, depression and renal failure (Hamilton, Gallagher, 
O’Mahony, 2009). Consequently, the prescription of PIM 
has also been associated with increased mortality and 
hospitalization among the elderly (Hamilton, Gallagher, 
O’Mahony, 2009; Ruggiero et al., 2010).
However, many prescribers are unaware of these 
tools, and the identification of PIM use among the elderly 
has been internationally documented in nursing homes 
(NH) (Ruggiero et al., 2010; Gutiérrez-Rodríguez, López-
Gaona, 2010; García-Gollarte et al., 2012) in hospitals 
(Gallagher, O’Mahony, 2008; Nagendra Vishwas et al., 
2012), emergency services (Dalleur et al., 2012) and the 
community (Cahir et al., 2010).
The use of PIM and the occurrence of PO are 
even more worrying when taking into consideration 
NH residents, since this population tends to have more 
debilitated health and functional status and uses more 
drugs (Braunseis et al., 2011). However, there are few 
studies investigating drug utilization in Brazilian NHs, 
and there are no studies applying the STOPP/START tool 
to assess geriatric prescription quality in Brazil.
The overall aim of this study was therefore to 
determine the health conditions and drug utilization 
patterns in the studied population, the prevalence of PIM 
use and associated factors, as well as the prevalence of PO.
METHODS
A cross-sectional observational study was conducted 
in a philanthropic NH located in the city of Divinopolis, 
Minas Gerais State, Brazil.
The eligible study population comprised all 
individuals aged 60 years or older (criteria for defining 
elderly subjects in developing countries), residing in the 
NH in September 2010.
The following information was collected from 
medical records and drug prescriptions: gender, age, health 
conditions and drugs used in the last thirty days.
Drugs prescribed were coded using the first and 
second level of the Anatomical Therapeutic Chemical 
(ATC) classification system (WHO, 2012). Polypharmacy 
was defined as the use of five or more drugs. PIM were 
identified according to the Beers’ Criteria (independent /
considering diagnosis or conditions) (Fick et al., 2003) 
and the Screening Tool for Older Persons’ Prescriptions 
(STOPP) (O’Mahony et al., 2010). Identification of PIM 
according to the STOPP also took into consideration the data 
from previous prescriptions in order to define the period of 
utilization. POs were detected using the Screening Tool to 
Alert to Right Treatment (START) (O’Mahony et al., 2010).
The present study was conducted in compliance 
with the standards required by the Helsinki Declaration 
and its ethical approval was granted by the Research 
Ethics Committee of the Educational Foundation of 
Divinopolis (FUNEDI) of the State University of Minas 
Gerais (UEMG) in May 2010, under ethical statement 
no. 27/2010.
Statistical analysis
A database to store the information gathered was 
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created on EpiInfo 3.5.3. Data were primarily analyzed 
through descriptive statistics: frequency distribution, 
measures of central tendency (mean and median) and 
dispersion (range and standard deviation).
The association between sex, age groups (60-79 and 
>79 years) and polypharmacy and PIM prescription was 
assessed using bivariate analyses. Pearson’s Chi-square 
test was performed for the comparison of proportions or 
Fisher’s exact test when pertinent. The selected association 
measure was the odds ratio with 95% confidence interval, 
estimated by logistic regression. For median comparison, 
the Mann-Whitney test was used. A 5% significance level 
was defined for all comparisons.
RESULTS
Study sample demographics and health 
conditions
All the elderly residents were included in the study 
(n=46). The detected mean±SD age was 80.5±8.5 years 
and 61% of the elderly were female.
A total of 49 diagnoses were identified on the 
medical charts (mean=1,1, ranging from 0 to 2) and the 
most frequent were: Hypertension (17.4%), Diabetes 
(15.2%), Senile Dementia (9.8%), Parkinson’s Disease 
(9.8%) and Bipolar Affective Disorder (9.8%).
In total, 95.7% of the population under study used 
at least one drug (n=44) and a total of 196 drugs was 
prescribed (mean±SD of 4.3 ± 2.7). Polypharmacy was 
prescribed to 38.6% of the residents (n=17).
The most frequently prescribed medications 
belonged to the “Nervous System” anatomical group 
(34.7%), followed by the “Cardiovascular System” 
(29.7%) and “Alimentary Tract and Metabolism” (17,9%). 
Taking into considerations the therapeutic classification, 
the “Psycholeptics” (14.8%) and “Diuretics” (9.7%) were 
the most prescribed group of drugs.
Prevalence of PIM use
Over one third (37%) of the population used at least 
one PIM according to Beers’ Criteria (n=17). Twenty 
(10.2%) out of the 196 prescribed drugs were classified 
as a PIM according to the Beers’ Criteria – independent 
of diagnosis or conditions (Table I), and only one of these 
(diazepam prescribed to an elder with urinary incontinence) 
was simultaneously classified as a PIM considering 
diagnosis or conditions. Diazepam was also the most 
prescribed PIM among the residents (prescribed to nine 
of the residents) followed by immediate release nifedipine 
(three residents) and amitriptyline (two residents).
Taking the STOPP tool into consideration, the 
prevalence rate of PIM use among residents was 60.9%. 
Among the medications consumed, 47 PIM were detected 
(24% of the drugs prescribed). Omeprazole (prescribed 
to 28.3% of the elderly; n=13), Diazepam (19.7%; n=9) 
and Haloperidol (10.9%; n=5) were the most frequently 
prescribed PIM (Table II). A statistically significant 
difference was found between the medians of number of 
PIM detected with the STOPP tool and the Beers’ Criteria 
(0.0 vs. 1.0 drug, respectively; p=0.006).
TABLE I - Frequency of potentially inappropriate medication prescription according to the Beers’ criteria
Potentially Inappropriate Medication Absolute Frequency (n)
Relative 
Frequency (%)
Diazepam – Prolonged sedation and increased risk of falls and fractures 9 45.0
Nifedipine – Potential for hypotension and constipation 3 15.0
Amitriptyline – Presents strong anticholinergic and sedation properties 2 10.0
Alprazolam (dose>2 mg) – Because of increased sensitivity to benzoadiazepines in 
elderly patients, smaller doses may be effective as well as safer
1 5.0
Amiodarone - Associated with QT interval problems and risk of provoking torsades de 
pointes. Lack of efficacy in older adults.
1 5.0
Digoxin (dose > 0.125 mg) - Decreased renal clearance may lead to increased risk of 
toxic effects
1 5.0
Doxazosin - Potential for hypotension, dry mouth, and urinary problems 1 5.0
Flurazepam - Prolonged sedation and increased risk of falls and fractures 1 5.0
Promethazine – Presents potent anticholinergic properties. 1 5.0
TOTAL 20 100
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Factors associated with PIM use
There was no association between age groups or sex 
and use of PIM according to the Beers’ Criteria (p=0.220 
and 0.828 respectively) or the STOPP (p=0.828 and 0.979). 
Polypharmacy was found to be associated with PIM 
identification according to the Beers’ Criteria (p<0.05), 
but not according to the STOPP tool (p=0.125) (Table III).
Prevalence of PO
With the application of the START tool, eight 
residents (17.4%) were found to be exposed to eight PO 
(Table IV).
TABLE II - Frequency of Potentially Inappropriate Medication prescription according to the STOPP
Potentially Inappropriate Medication Absolute Frequency (n)
Relative 
Frequency (%)
Omeprazole – Proton pump inhibitor for peptic ulcer disease at full therapeutic dosage 
for > 8 weeks
13 27.7
Diazepam – Long-term (i.e.>1 month) long-acting benzodiazepines 9 19.1
Haloperidol – Long-term (i.e.>1 month) neuroleptics as long-term hypnotics 5 10.6
Biperiden – Anticholinergics to treat extrapyramidal side-effects of neuroleptic 
medications
2 4.3
Chlorpromazine – Long-term (i.e.>1 month) neuroleptics as long-term hypnotics 2 4.3
Furosemide – Loop diuretic as first-line monotherapy for hypertension 2 4.3
Loperamide – Loperamide for treatment of diarrhoea of unknown cause 2 4.3
Alprazolam – Drug that adversely affect those prone to falls (≥1 fall in past 3 months) 1 2.1
Bromazepam - Drug that adversely affect those prone to falls (≥1 fall in past 3 months) 1 2.1
Carvedilol – Betablocker in combination with verapamil 1 2.1
Digoxin – Digoxin at a long-term dose > 125 µg/day with impaired renal function 1 2.1
Etodolac – Non-steroidal anti-inflammatory drug with moderate-severe hypertension 1 2.1
Flurazepam – Long-term (i.e.>1 month), long-acting benzodiazepines 1 2.1
Glibenclamide – Glibenclamide with type 2 diabetes mellitus (risk of prolonged 
hypoglycaemia)
1 2.1
Levomepromazine – Long-term (i.e.>1 month) neuroleptics as long-term hypnotics 1 2.1
Nifedipine – Calcium channel blockers with chronic constipation 1 2.1
Prednisone – Long-term corticosteroid as monotherapy for rheumatoid arthritis 1 2.1
Promethazine – Prolonged use of first generation antihistamines (risk of sedation and 
anticholinergic side effects)
1 2.1




TABLE III - Association with PIM use analysis
Variables Use of PIM – Beers’ Criteria p value / OR (95% CI)
Use of PIM – STOPP 
p value / OR (95% CI)
Age groups (60-79 and >79 years) 0.220 / 2.13 (0.63-7.25) 0.729 / 0.81 (0.24-2.68)
Sex 0.828 / 0.87 (0.26-2.97) 0.979 / 0.98 (0.29-3.31)
Polypharmacy 0.019 / 4.49 (1.24-16.26) 0.125 / 3.03 (0.80-11.54)
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TABLE IV - Frequency of prescribing omissions
Prescribing Omission Absolute Frequency (n)
Relative 
Frequency (%)
Aspirin or clopidogrel with a documented history of atherosclerotic coronary, cerebral or 
peripheral disease in patients with sinus rhythm
3 37.5
Angiotensin-converting-enzyme inhibitor with chronic heart failure 2 25.0
Levodopa in idiopathic Parkinson’s disease with definitive functional impairment and 
resultant disability
1 12.5
Bisphosphonates in patients taking maintenance oral corticosteroid therapy 1 12.5
Antiplatelet therapy in diabetes mellitus IF one or more co-existing major cardiovascular 
risk factors present 
1 12.5
DISCUSSION
Like in the present NH under study, hypertension 
was one of the most frequent diagnoses identified in 
other Brazilian NHs, and likewise in Italy, Spain and 
Norway (Correr et al., 2007; Danilow et al., 2007; Aguiar 
et al., 2008; Araújo et al., 2008; Gonçalves et al., 2008; 
Gutiérrez-Rodriguez, López Gaona, 2010; Halvorsen et 
al., 2010). This portrays the escalating prevalence and 
mortality of cardiovascular diseases detected in Brazil and 
worldwide (IBGE, 2010).
The average number of drugs used (4.3 ± 2.7) 
detected in the present study was similar to the average 
number of drugs detected by Araújo et al. (2008) in 
another Brazilian NH (average = 4.8 drugs/elderly). The 
average proved higher however, than those detected by 
Aguiar et al. (2008) and Correr et al. (2007) in two other 
Brazilian NHs (2.7 and 3.0 respectively), but lower than 
those detected in a Belgian NH by Azermai et al. (2011) 
(average = 7), and by Gutierrez-Rodríguez & López-
Gaona (2010) and García-Gollarte et al. (2012) in Spanish 
NHs (averages of 6.3 and 6.5, respectively). Nonetheless, 
the higher the number of drugs used by the elderly, the 
higher the level of therapeutic complexity.
Mirroring other studies, the most prescribed drugs 
were those used to treat diseases of the nervous system 
and cardiovascular system (Castellar et al., 2007; Correr 
et al., 2007; Aguiar et al., 2008; Gutiérrez-Rodriguez, 
López Gaona, 2010). However, in most cases, the 
anatomical group “Cardiovascular System” tends to 
rank first, but this was not the case in the present study 
(Castellar et al., 2007; Correr et al., 2007; Danilow et 
al., 2007; Aguiar et al., 2008; Gutiérrez-Rodriguez, 
López Gaona, 2010). This may indicate excessive 
and irrational prescription of Nervous System acting 
drugs or inadequate diagnosis, since drugs classified as 
psycholeptics were the most prescribed. This group of 
drugs can reduce functionality and predispose the elderly 
to falls.
In the present study, the percentage of elderly using 
at least one PIM according to the Beers’ Criteria (38.6% 
of medication users) was high, indicating a possible 
lack of knowledge regarding the Beers’ Criteria among 
prescribers, representing a higher rate than that detected 
by Aguiar et al. (2008) (32.9%) and Varallo et al. (2012) 
(29,2%) in Brazil.
The prevalence of PIM according to the Beers’ 
Criteria among the prescribed drugs (10.2%) was similar 
to the rate detected by Correr et al. (2007) in Apucarana 
- Brazil (13.5%). In both these Brazilian studies, short 
acting nifedipine and amitriptyline were among the 
three most prescribed PIM, and in a study by Aguiar et 
al. (2008), amitriptyline was the most prescribed PIM. 
Diazepam, the most prescribed PIM in the present study, 
however, ranked only fourth in the studies by Correr et al. 
(2007) and Aguiar et al. (2008).
It is noteworthy that the three most prescribed PIM 
in the present study (diazepam, short acting nifedipine and 
amitriptyline) predispose the elderly to falls and fractures 
due to its pronounced sedation effect or increased risk of 
hypotension (Fick et al., 2003).
As for the identification of only one PIM considering 
diagnosis or conditions according to the Beers’ Criteria, 
this is believed to be an underestimated indicator, due 
to the low quality of the patient charts in the studied 
institution.
Using the STOPP, however, the number of PIM 
detected was higher (n=47, 24% of the prescribed drugs) 
and prescribed to a higher number of individuals (n=28, 
63.6% of the medications users), despite the fact that 
STOPP contains less criteria for potentially inappropriate 
prescribing than the Beers’ Criteria. No Brazilian studies 
with the use of the STOPP have been published, but 
international studies in NHs in Spain conducted by 
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García-Gollarte et al. (2012) in Valencia and Gutierrez-
Rodríguez and López-Gaona (2010) in Asturia both 
detected greater prevalences than that detected in the 
present study (79% and 71.4%, respectively) (Gutiérrez-
Rodríguez, López-Gaona., 2010; García-Gollarte et al., 
2012).
The three most prescribed PIMs according to the 
STOPP were: omeprazole, diazepam (also identified as the 
most prescribed PIM according to the Beers’ Criteria in the 
present institution) and haloperidol. In the study conducted 
by García-Gollarte et al. (2012), the most prescribed PIM 
were also proton-pump inhibitors, benzodiazepines and 
antipsychotic drugs. Once again, the fact that the latter two 
drug groups predispose the elderly to falls and/or fractures 
draws attention (Fick et al., 2003).
As established by international studies, the present 
study also detected a statistically significant difference 
between the number of PIM identified by the Beers’ 
Criteria and the STOPP, indicating that the latter tool has 
a higher potential for detecting unsafe prescription that can 
lead to drug-related adverse events (Hamilton, Gallagher, 
O’Mahony, 2009). However, no association between sex, 
age and use of PIM was encountered.
The prevalence of polypharmacy among the 
residents was high (37%) and greater than the prevalence 
detected in other national studies (Castellar et al., 2007; 
Correr et al., 2007; Danilow et al., 2007; Aguiar et al., 
2008; Gonçalves et al., 2008). Polypharmacy exposes the 
elderly to a higher risk of developing adverse events and, 
for this reason, should only be employed when the use 
of multiple drugs is indispensable (McLean, Le Couteur, 
2004; Kostoff, Delafuente, 2006; Viktil et al., 2007; 
Hajjar, Cafiero, Hanlon, 2007). The association between 
polypharmacy and the use of PIM according to the Beers’ 
Criteria detected in the present study corroborates with 
this fact. However, no association between polypharmacy 
and the use of PIM was identified according to the STOPP, 
unlike other studies conducted in hospitals (Gallagher et 
al., 2011).
The use of the START enabled the detection of PO 
for a substantial proportion of the studied population 
(17.4% of the elderly), however, it is believed that this 
value was underestimated due to problems concerning the 
documentation of health problems in the medical records/
charts and insufficient medical assistance.
To date, there are no studies in Brazil that show 
the use of the START, but the few international studies 
published show a higher frequency of PO among the 
elderly (52.4% detected in Asturias and 74% in Valencia) 
(Gutiérrez-Rodríguez, López-Gaona, 2010; García-
Gollarte et al., 2012).
The non-prescription of agents in a bid to 
reduce cardiovascular risk was the most common 
inappropriateness identified with the START (among six 
elderly). However, it is important to point out that the two 
patients with no angiotensin converting enzyme inhibitor 
(ACEI) in their prescriptions who had chronic heart 
failure used losartan (an angiotensin II antagonist that 
can substitute ACEI in cases where the patient develops 
adverse drug reactions to the latter).
Another PO detected was the need for prescription 
of antithrombotic agents to patients with diabetes 
and high cardiovascular risk (n=1). Nevertheless, in 
the light of recent knowledge, this practice has been 
questioned, since there are no studies showing that the 
use of aspirin reduces the risk of cardiovascular events 
in diabetic patients (Berger et al., 2011). Besides, the use 
of aspirin in low doses has been increasingly associated 
with the development of gastrointestinal bleeding, an 
adverse drug reaction especially dangerous in patients 
with diabetes mellitus, since this group tends to have 
an increased risk of presenting such events (up to 55%) 
(Berger et al., 2011).
In contrast with the present study, in Valencia, 
Spain, the most commonly detected PO in NH were 
nonprescription of vitamin D, statins and aspirin (García-
Gollarte et al., 2012).
CONCLUSIONS
Despite the small number of subjects, the present 
study allowed the diagnosis of a concerning drug 
utilization profile. Although the clinical outcomes of 
the drug therapy were not analyzed, the high number of 
inadequacies indicates a low level therapeutic decision 
process in the studied institution.
Thus, there is an evident need to implement 
strategies for improving geriatric prescription and 
clinical documentation. Pharmacists assuming the role 
of being co-responsible for geriatric drug therapy, as 
well as propagators of global knowledge in this area, 
represents a plausible alternative that could generate 
positive results, as described in the literature (Romano-
Lieber et al., 2002).
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